Sensible Medical Innovations

8 articles about Sensible Medical Innovations

• Sensible Medical announces Successful IIS RCT Publication - The ReDS-SAFE HF Trial

  3/7/2024

  Sensible Medical , creator of the ReDS pulmonary congestion monitor, announces the publication of The ReDS-SAFE HF Trial; an international, multicenter, investigator initiated, randomized controlled trial, demonstrating a significant improvement in heart failure patients' clinical outcomes by utilizing Remote Dielectric Sensing (ReDS)

• New Partnership Restores Confidence For Safe Surgery During COVID-19

  7/15/2020

  Sensible Medical signs exclusive distribution agreement with Toul Meditech for Operio® Mobile and SteriStay® Clean Air Zone Systems.

• Sensible Medical announces ReDS™ Pro, the next generation of market leading lung fluid management technology for heart failure

  9/14/2019

  Non-invasive monitoring technology assists in managing heart failure patients

• Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States

  1/28/2019

  Medicure Inc., a cardiovascular pharmaceutical company, is pleased to announce it has entered into an agreement with Sensible Medical Innovations Inc. to become the exclusive marketing partner for the ReDS™ point of care system in the United States.

• First Patient Enrolled in The SMILE Study, Sensible Medical Innovations's Randomized Controlled Trial (RCT) Designed To Measure ReDS Technology Impact On Heart Failure Rehospitalizations

  10/20/2015

• Sensible Medical Innovations Release: ReDS HF Study Demonstrating Benefits Of ReDS Guided Patient Management Presented At HFSA Conference

  9/28/2015

• Sensible Medical Innovations Raises $20 Million, Boston Scientific Corporation Leads Investment

  11/11/2013

• Israel's Sensible Medical Innovations Opens its First U.S. Location in Columbus, Ohio., New Jobs Expected

  2/18/2010